Moderna and Mitsubishi Tanabe Pharma ink agreement to promote Moderna’s mRNA respiratory vaccine portfolio in Japan
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The agreement has an initial term until March 31, 2029 and no further details on the financial terms of the deal are being disclosed
The Unit has been issued GMP Certification from ANVISA-Brazil
The approved ANDA is therapeutically equivalent to the reference listed drug product
Utidelone can penetrate BBB due to its unique physicochemical characteristics and insusceptibility to P-glycoprotein-mediated efflux
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
The initiative aims to empower individuals to take proactive steps towards monitoring their health
Laurus Labs receives EIR from USFDA for API facilities
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Doxycycline capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients
Subscribe To Our Newsletter & Stay Updated